Fed Regist. 2008 Sep 18;73(182):54207-23.
This final rule revises the Medicare Advantage (MA) program (Part C) and Medicare Prescription Drug Benefit Program (Part D). The regulation contains new regulatory provisions regarding marketing processes for both programs. The revisions to the Part C and Part D programs are based on lessons we have learned since 2006, the initial year of the prescription drug program and the revised MA program.
本最终规则修订了医疗保险优势(MA)计划(C部分)和医疗保险处方药福利计划(D部分)。该法规包含了有关这两个计划营销流程的新监管规定。对C部分和D部分计划的修订基于我们自2006年以来所吸取的经验教训,2006年是处方药计划和修订后的MA计划的起始年份。